Loading...
XKRX161890
Market cap883mUSD
Dec 24, Last price  
54,500.00KRW
1D
0.18%
1Q
-24.93%
Jan 2017
-17.17%
IPO
93.61%
Name

Kolmar Korea Co Ltd

Chart & Performance

D1W1MN
XKRX:161890 chart
P/E
247.79
P/S
0.60
EPS
219.94
Div Yield, %
1.29%
Shrs. gr., 5y
0.77%
Rev. gr., 5y
9.68%
Revenues
2.16t
+15.54%
282,228,682,720461,252,659,670535,846,082,250667,469,194,150821,615,970,1901,357,865,265,1901,540,720,628,9601,322,081,317,6601,586,332,710,2501,865,731,523,0302,155,675,927,420
Net income
5.19b
P
14,060,089,74032,806,096,79045,479,278,76053,079,052,67047,261,870,19042,307,152,80029,057,851,620160,269,947,48035,811,330,530-4,101,004,6805,191,815,100
CFO
112.24b
+23.60%
24,947,363,78034,419,374,90049,420,179,91038,213,822,3405,386,484,25062,759,621,620164,842,538,880121,463,641,010-3,122,843,67090,811,567,580112,241,475,350
Dividend
Dec 27, 2023600 KRW/sh
Earnings
Feb 25, 2025

Profile

Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers various cosmetic products, including skin care, makeup, baby, hair care, and body care products, as well as perfume, functional cosmetics, and qusi drugs. The company also provides prescription, over-the-counter, and bioequivalent drugs; drugs for dermatology and circulatory system; ointment and external, and oral solutions; and oral solids. In addition, it offers health functional food comprising health supplements; ingredients; special purpose food; and individually recognized health supplements. The company was founded in 2012 and is headquartered in Sejong, South Korea.
URL
https://www.kolmar.co.kr/
IPO date
Oct 19, 2012
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,155,675,927
15.54%
1,865,731,523
17.61%
1,586,332,710
19.99%
Cost of revenue
1,792,555,437
1,600,018,989
1,333,656,205
Unusual Expense (Income)
NOPBT
363,120,490
265,712,534
252,676,505
NOPBT Margin
16.84%
14.24%
15.93%
Operating Taxes
9,199,172
21,074,800
23,007,852
Tax Rate
2.53%
7.93%
9.11%
NOPAT
353,921,318
244,637,735
229,668,654
Net income
5,191,815
-226.60%
(4,101,005)
-111.45%
35,811,331
-77.66%
Dividends
(16,606,635)
(11,751,190)
(7,893,845)
Dividend yield
1.35%
1.21%
0.86%
Proceeds from repurchase of equity
(24,180,981)
401,702,299
BB yield
2.48%
-43.62%
Debt
Debt current
853,960,460
532,079,572
591,627,147
Long-term debt
314,853,160
589,137,676
373,559,770
Deferred revenue
1,214,795
514,354
580,545
Other long-term liabilities
9,676,844
8,248,182
6,036,362
Net debt
815,721,035
867,396,644
743,154,526
Cash flow
Cash from operating activities
112,241,475
90,811,568
(3,122,844)
CAPEX
(124,728,900)
(57,453,104)
(51,357,347)
Cash from investing activities
(155,684,341)
(145,246,118)
(283,006,750)
Cash from financing activities
(8,409,315)
82,026,021
97,633,464
FCF
278,512,494
63,974,523
169,231,063
Balance
Cash
280,261,977
297,396,654
424,226,526
Long term investments
72,830,608
(43,576,051)
(202,194,136)
Excess cash
245,308,789
160,534,027
142,715,755
Stockholders' equity
1,156,282,905
1,226,761,690
1,109,900,742
Invested Capital
2,287,005,307
2,358,934,023
2,109,544,909
ROIC
15.24%
10.95%
12.01%
ROCE
14.08%
10.33%
11.05%
EV
Common stock shares outstanding
22,881
22,881
22,881
Price
53,600.00
25.82%
42,600.00
5.84%
40,250.00
-20.92%
Market cap
1,226,431,248
25.82%
974,738,268
5.84%
920,966,448
-20.92%
EV
2,812,120,303
2,647,511,514
2,340,075,014
EBITDA
456,848,593
341,137,453
311,048,442
EV/EBITDA
6.16
7.76
7.52
Interest
45,064,091
32,694,822
30,607,043
Interest/NOPBT
12.41%
12.30%
12.11%